Literature DB >> 2388995

Precocious familial gout with reduced fractional urate clearance and normal purine enzymes.

G Calabrese1, H A Simmonds, J S Cameron, P M Davies.   

Abstract

Gout is primarily a disease of middle-aged males and is unusual in females and adolescent males. We describe 21 young men and women (mean age 28 years) referred because of precocious onset of gout or hyperuricaemia. Fifteen patients had a family history, but known hereditary causes of primary or secondary hyperuricaemia were excluded. A high proportion (14/21) also had reduced renal function, but there was no clear relationship between this and the hyperuricaemia. Only two patients were hypertensive. A striking abnormality was that the uric acid clearance relative to creatinine [FEur] was subnormal (mean 4.4 +/- 1.4 per cent) in 15/21 patients, including all seven females. A dominantly inherited defect in renal tubular urate handling, leading to a reduced endogenous urate clearance, is the most likely explanation for the hyperuricaemia in this group. Only six patients, all male had a normal [FEur] (mean 8.6 +/- 1.0 per cent). The results confirm that young men and women with gout-or hyperuricaemia disproportionate to the renal dysfunction-should always be investigated, not only for purine defects, but also for abnormalities of renal urate handling. Since the abnormality described here was found also in symptomless subjects, the families of such patients must also be studied. Early identification is important since treatment may ameliorate the renal damage. Although rare, the number of such patients seen in a single referral unit suggests that this type of renal tubular defect in urate handling is more common than suspected and may only come to attention through an isolated episode of precocious gout, when renal function may already be impaired.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2388995

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  8 in total

Review 1.  Investigation and management of gout in the young and the elderly.

Authors:  P A Dieppe
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

2.  Gout in black South Africans: a clinical and genetic study.

Authors:  B Cassim; G M Mody; V K Deenadayalu; M G Hammond
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

3.  Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.

Authors:  Guillaume Bollée; Karin Dahan; Martin Flamant; Vincent Morinière; Audrey Pawtowski; Laurence Heidet; Didier Lacombe; Olivier Devuyst; Yves Pirson; Corinne Antignac; Bertrand Knebelmann
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 8.237

Review 4.  From juvenile hyperuricaemia to dysfunctional uromodulin: an ongoing metamorphosis.

Authors:  Gopalakrishnan Venkat-Raman; Christine Gast; Anthony Marinaki; Lynnette Fairbanks
Journal:  Pediatr Nephrol       Date:  2016-02-12       Impact factor: 3.714

Review 5.  Gout, uric acid and purine metabolism in paediatric nephrology.

Authors:  J S Cameron; F Moro; H A Simmonds
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

6.  Clinical and family studies in Hungarian patients with gout.

Authors:  M Mituszova; A Judák; G Poór; E Gyódi; V Stenszky
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

Review 7.  New developments in the epidemiology and genetics of gout.

Authors:  Raihana Zaka; Charlene J Williams
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.686

Review 8.  Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics.

Authors:  Robert Terkeltaub; David A Bushinsky; Michael A Becker
Journal:  Arthritis Res Ther       Date:  2006-04-12       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.